Literature DB >> 478633

Immunological specificity of heat-stable opsonins in immune and nonimmune sera and their interaction with non-encapsulated and encapsulated strains of Staphylococcus aureus.

W W Karakawa, D A Young.   

Abstract

The in vitro interactions between strains of Staphylococcus aureus and human polymorphonuclear leukocytes in the presence of immune and nonimmune sera were studied. Evidence indicated that phagocytosis of encapsulated strains occurred in the presence of specific homologous antiserum, whereas non-encapsulated strains were readily phagocytized by polymorphonuclear leukocytes in the presence of both normal and immune sera. Immunological analyses demonstrated that normal serum opsonins, which reacted with the non-encapsulated strains, were specifically directed against exposed mucopeptide moieties of the organisms. Sera rich in antimucopeptide antibodies were obtained from rabbits immunized with heterologous bacteria such as Escherichia coli and group A-variant streptococci and were shown to be effective in opsonizing the non-encapsulated strains of S. aureus. Fresh clinical isolates of S. aureus were noticeably more resistant to the opsonizing effects of the antimucopeptide antibodies. Results were presented which suggest that the surface structures of these clinical isolates are more diverse than laboratory-propagated strains and that these antiphagocytic surface antigens may be significant factors in masking the opsonizing effects of the mucopeptide opsonins which are present in most sera.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 478633      PMCID: PMC414435          DOI: 10.1128/iai.25.1.175-186.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Mutants of staphylococci with altered cell walls.

Authors:  J T Park; D R Shaw; A N Chatterjee; D Mirelman; T Wu
Journal:  Ann N Y Acad Sci       Date:  1974-07-31       Impact factor: 5.691

2.  Structure of the cell wall of Staphylococcus aureus, strain Copenhagen. VII. Mode of action of the bacteriolytic peptidase from Myxobacter and the isolation of intact cell wall polysaccharides.

Authors:  D J Tipper; J L Strominger; J C Ensign
Journal:  Biochemistry       Date:  1967-03       Impact factor: 3.162

3.  Structural analysis of the cellular constituents of a fresh clinical isolate of Staphylococcus aureus, and their role in the interaction between the organisms and polymorphonuclear leukocytes in the presence of serum factors.

Authors:  W W Karakawa; D A Young; J A Kane
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

4.  Immune response to surface antigens of Staphylococcus aureus and their role in resistance to staphylococcal disease.

Authors:  R D Ekstedt
Journal:  Ann N Y Acad Sci       Date:  1974-07-31       Impact factor: 5.691

5.  The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.

Authors:  R B Roberts
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

6.  Immunochemical analysis of a Smith-like antigen isolated from two human strains of Staphylococcus aureus.

Authors:  W W Karakawa; J A Kane
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

7.  The key role of peptidoglycan in the opsonization of Staphylococcus aureus.

Authors:  P K Peterson; B J Wilkinson; Y Kim; D Schmeling; S D Douglas; P G Quie; J Verhoef
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

8.  Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.

Authors:  P K Peterson; B J Wilkinson; Y Kim; D Schmeling; P G Quie
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

9.  Multiple polysaccharide antigens of group B streptococcus, type Ia: emphasis on a sialic acid type-specific polysaccharide.

Authors:  J A Kane; W W Karakawa
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

10.  Immunochemical studies on the cross-reactivity between streptococcal and staphylococcal mucopeptide.

Authors:  W W Karakawa; D G Braun; H Lackland; R M Krause
Journal:  J Exp Med       Date:  1968-08-01       Impact factor: 14.307

View more
  6 in total

1.  Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains.

Authors:  B Poutrel; F B Gilbert; M Lebrun
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

2.  Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus.

Authors:  W W Karakawa; J M Fournier; W F Vann; R Arbeit; R S Schneerson; J B Robbins
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

3.  Phagocytosis of mastitis isolates of Staphylococcus aureus and expression of type 5 capsular polysaccharide are influenced by growth in the presence of milk.

Authors:  L Sutra; P Rainard; B Poutrel
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

4.  Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide.

Authors:  J M Fournier; W F Vann; W W Karakawa
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits.

Authors:  D P Greenberg; J I Ward; A S Bayer
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis.

Authors:  B J Wilkinson; S P Sisson; Y Kim; P K Peterson
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.